Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 240

1.

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.

Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME.

N Engl J Med. 1994 Sep 8;331(10):637-42.

2.

[Clinical development of rhDNase in the United States].

Eisenberg J.

Arch Pediatr. 1995 Jul;2(7):674-8. French.

PMID:
7663659
3.

Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.

Shak S.

Chest. 1995 Feb;107(2 Suppl):65S-70S. Review.

PMID:
7842816
4.

Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group.

Harms HK, Matouk E, Tournier G, von der Hardt H, Weller PH, Romano L, Heijerman HG, FitzGerald MX, Richard D, Strandvik B, Kolbe J, Kraemer R, Michalsen H.

Pediatr Pulmonol. 1998 Sep;26(3):155-61.

PMID:
9773909
5.

Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I.

Shah PL, Scott SF, Fuchs HJ, Geddes DM, Hodson ME.

Thorax. 1995 Apr;50(4):333-8.

6.

[Multicenter study of rhDNase in cystic fibrosis with severe pulmonary involvement].

Hodson M.

Arch Pediatr. 1995 Jul;2(7):679-81. French.

PMID:
7663660
7.

[Socioeconomic evaluation of the effect of rhDNase on the cost of treating infections of the respiratory tract in patients with cystic fibrosis].

von der Schulenburg JM, Greiner W, von der Hardt H.

Med Klin (Munich). 1995 Apr 15;90(4):220-4. German.

PMID:
7776934
8.

In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis.

Shah PL, Scott SF, Knight RA, Marriott C, Ranasinha C, Hodson ME.

Thorax. 1996 Feb;51(2):119-25.

9.

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.

Quan JM, Tiddens HA, Sy JP, McKenzie SG, Montgomery MD, Robinson PJ, Wohl ME, Konstan MW; Pulmozyme Early Intervention Trial Study Group.

J Pediatr. 2001 Dec;139(6):813-20.

PMID:
11743506
10.

Effect of aerosolized rhDNase (Pulmozyme) on pulmonary colonization in patients with cystic fibrosis.

Frederiksen B, Pressler T, Hansen A, Koch C, Høiby N.

Acta Paediatr. 2006 Sep;95(9):1070-4.

PMID:
16938752
11.
12.

Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations.

Wilmott RW, Amin RS, Colin AA, DeVault A, Dozor AJ, Eigen H, Johnson C, Lester LA, McCoy K, McKean LP, Moss R, Nash ML, Jue CP, Regelmann W, Stokes DC, Fuchs HJ.

Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1914-7.

PMID:
8665055
13.

Safety of repeated intermittent courses of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.

Eisenberg JD, Aitken ML, Dorkin HL, Harwood IR, Ramsey BW, Schidlow DV, Wilmott RW, Wohl ME, Fuchs HJ, Christiansen DH, Smith AL.

J Pediatr. 1997 Jul;131(1 Pt 1):118-24.

PMID:
9255202
14.

Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment.

Shah PI, Bush A, Canny GJ, Colin AA, Fuchs HJ, Geddes DM, Johnson CA, Light MC, Scott SF, Tullis DE, et al.

Eur Respir J. 1995 Jun;8(6):954-8.

15.

[Effect of rhDNase on the respiratory function and nutritional status of children and adolescents with mucoviscidosis].

Wizla-Derambure N, Michaud L, Sardet A, Deschildre A, Loeuille GA, Tassin E, Loire N, Buisine C, Boutry E, Dias J, Hecquet F, Turck D.

Arch Pediatr. 1998 Apr;5(4):378-83. French.

PMID:
9759156
16.

Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis.

Ranasinha C, Assoufi B, Shak S, Christiansen D, Fuchs H, Empey D, Geddes D, Hodson M.

Lancet. 1993 Jul 24;342(8865):199-202.

PMID:
8100928
17.

Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.

Laube BL, Auci RM, Shields DE, Christiansen DH, Lucas MK, Fuchs HJ, Rosenstein BJ.

Am J Respir Crit Care Med. 1996 Feb;153(2):752-60.

PMID:
8564129
18.

Recombinant human DNase in children with airway malacia and lower respiratory tract infection.

Boogaard R, de Jongste JC, Vaessen-Verberne AA, Hop WC, Merkus PJ.

Pediatr Pulmonol. 2009 Oct;44(10):962-9. doi: 10.1002/ppul.21073.

PMID:
19768804
20.

Supplemental Content

Support Center